Abstract

The autism spectrum disorders (ASD) are a heterogeneous set of neurodevelopmental syndromes defined by impairments in verbal and non-verbal communication, restricted social interaction, and the presence of stereotyped patterns of behavior. The prevalence of ASD is rising, and the diagnostic criteria and clinical perspectives on the disorder continue to evolve in parallel. Although the majority of individuals with ASD will not have an identifiable genetic cause, almost 25% of cases have identifiable causative DNA variants. The rapidly improving ability to identify genetic mutations because of advances in next generation sequencing, coupled with previous epidemiological studies demonstrating high heritability of ASD, have led to many recent attempts to identify causative genetic mutations underlying the ASD phenotype. However, although hundreds of mutations have been identified to date, they are either rare variants affecting only a handful of ASD patients, or are common variants in the general population conferring only a small risk for ASD. Furthermore, the genes implicated thus far are heterogeneous in their structure and function, hampering attempts to understand shared molecular mechanisms among all ASD patients; an understanding that is crucial for the development of targeted diagnostics and therapies. However, new work is beginning to suggest that the heterogeneous set of genes implicated in ASD may ultimately converge on a few common pathways. In this review, we discuss the parallel evolution of our diagnostic and genetic understanding of autism spectrum disorders, and highlight recent attempts to infer common biology underlying this complicated syndrome.

Highlights

  • Specialty section: This article was submitted to Behavioral and Psychiatric Genetics, a section of the journal Frontiers in Genetics

  • New work is beginning to suggest that the heterogeneous set of genes implicated in autism spectrum disorders (ASD) may converge on a few common pathways

  • The development of microarray technology such as comparative genomic hybridization (CGH), allowed the unbiased assessment of copy-number variation (CNV) across the whole genome at a resolution of as low as 100 kilobases (Alkan et al, 2011). The first of these analysis indicated that individuals with ASD had 10–20 times the number of CNVs as controls (Jacquemont et al, 2006; Sebat et al, 2007)

Read more

Summary

Evolving Diagnostic and Genetic Landscapes of Autism Spectrum

The autism spectrum disorders (ASD) are a heterogeneous set of neurodevelopmental syndromes defined by impairments in verbal and non-verbal communication, restricted social interaction, and the presence of stereotyped patterns of behavior. The genes implicated far are heterogeneous in their structure and function, hampering attempts to understand shared molecular mechanisms among all ASD patients; an understanding that is crucial for the development of targeted diagnostics and therapies. New work is beginning to suggest that the heterogeneous set of genes implicated in ASD may converge on a few common pathways. We discuss the parallel evolution of our diagnostic and genetic understanding of autism spectrum disorders, and highlight recent attempts to infer common biology underlying this complicated syndrome

CLINICAL PHENOTYPE AND INCIDENCE
GENETIC ETIOLOGY
GENOMIC ARCHITECTURE OF ASD
FROM ASD CANDIDATE GENES TO CANDIDATE PATHWAYS
Findings
CONCLUSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.